eMosquito is focused on the development and marketing of innovative autonomous technologies aimed to disrupt the blood glucose monitoring industry. The companies lead product candidate is a smart-insole which facilitates convenient and pain free blood sampling for diabetic patients. The company is interested in bring to market this product independently or through a partnership with a large incumbent with distribution expertise and resources.